A precedent for this exists, it seems to me, in the Kefauver Drug Amendments of 1962, which provide that prescription-drug advertising must carry brief summaries about specific conditions that might be brought about in patients through the use of the drugs being advertised
(2) reporting a serious, unstable psychiatric condition (e.g., bipolar disorder, schizophrenia), (3) reporting a serious, unstable physical health condition that would increase risk of study participation determined by medical history interview and review by study physician (e.g., past or present cardiac problems, respiratory problems, overnight hospitalization in the past 3 months), (4) current criteria for DSM-5 moderate or severe cannabis use disorder, (5) current use of other psychoactive substances confirmed by urine drug screening, unless prescribed and stable for 2 months, (6) living with someone who currently smokes menthol cigarettes, to reduce access to preferred cigarettes during the switching phase of the study, consistent with our pilot [19], (7) known allergy to PG/VG in e-liquid, (8) female participants will be excluded if they are currently pregnant, planning to become pregnant, breastfeeding, or unwilling to use an effective method of birth control for the duration of the study, (9) abnormal spirometry test, (10) if reporting recent cannabis vaping (past 90 days), additional exclusion will be any report of mild or greater EVALI-related symptoms (e.g., cough, shortness of breath, chest pain) without non-EVALI reasonable and proximal cause
He says about 1.5% of smokers each year go for the optimal treatment of drugs and behavioural support, when that should be 2030%
Brand Family: Marlboro Product Type: Cigarettes Country: Thailand City: Chiang Mai Collection Date: December, 2013 Price: 78.00 THB (2.43 USD) Stick count: 20 *Selecting any of the linked attributes above will open a new search, showing all packs that match this attribute.
